Skip to main content
. Author manuscript; available in PMC: 2015 Apr 7.
Published in final edited form as: Antivir Ther. 2008;13(0 2):59–68.

Figure 1.

Figure 1

An overview of the steps used to create the provisional list of surveillance drug resistance mutations

Beneath each step is a description of the specific approach used. Possible alternatives to the approaches used to derive the provisional surveillance drug resistance mutations (SDRMs) list are reviewed in this article.